Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders

Enrolling by invitationOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

November 30, 2050

Study Completion Date

November 30, 2050

Conditions
PSPCBDPCALPASemantic DementiaSemantic AphasiaBehavioral Variant of Frontotemporal DementiaFTDPPAApraxia of SpeechMSA - Multiple System AtrophyParkinson Disease
Interventions
DRUG

C-11 PiB

Completing PET scan looking for amyloid protein

DRUG

AV1451 Tau

Completing PET scan looking for tau protein

DRUG

C-11 ER176

Completing PET scan looking for neuroinflammation

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER